Study to Evaluate Safety and Activity of TRL1068 in Prosthetic Joint Infections
Public ClinicalTrials.gov record NCT04763759. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Blinded, Single Ascending Dose Study to Evaluate Safety, Pharmacokinetics, and Activity of TRL1068 in Subjects With Prosthetic Joint Infection of the Knee or Hip, Undergoing Primary Two Stage Exchange Arthroplasty
Study identification
- NCT ID
- NCT04763759
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Trellis Bioscience LLC
- Industry
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- TRL1068, a human monoclonal antibody Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 7, 2021
- Primary completion
- Mar 12, 2024
- Completion
- Mar 12, 2024
- Last update posted
- Nov 20, 2024
2021 – 2024
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35205 | — |
| USC | Los Angeles | California | 90033 | — |
| UCLA | Santa Monica | California | 90404 | — |
| University of Florida | Gainesville | Florida | 32611 | — |
| Gulfcoast Research Institute | Sarasota | Florida | 34232 | — |
| Phoenix Clinical Research | Tamarac | Florida | 33321 | — |
| Sinai Hospital of Baltimore | Baltimore | Maryland | 21215 | — |
| Houston Methodist Research Institute | Houston | Texas | 77030 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04763759, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04763759 live on ClinicalTrials.gov.